FDA Import Refusal SCS-0006802-8/13/1 — DAEWOONG PHARMACEUTICAL CO LTD
The FDA refused shipment SCS-0006802-8/13/1 from DAEWOONG PHARMACEUTICAL CO LTD (South Korea) on Jun 4, 2025. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charges: 118,3260,3280,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 4, 2025
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 58PAY05 ONABOTULINUMTOXINA
- Charges
- 118,3260,3280,75